Observational Cohort Study of TachoSil (TC-018-IN)
Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to collect information, after exposure to TachoSil ®, of all
thromboembolic events, immunological events and drug interactions leading to thromboembolic
events or major bleeding. In addition, pharmacoeconomic data will be collected.